- Am Klopferspitz 19a
- 82152 Planegg / Martinsried
- Phone: +49 89 54199929
Jens Klein, CEO
Insempra is a biology powered company enabling businesses to make superior products with nature. We combine bioscience and technology to grow matter for new and better products.
Businesses have relied on chemical industrialization processes and petrochemicals for too long, depleting our planet’s limited resources. That’s why we are committed to driving the regenerative revolution to manufacture at scale, in collaboration with nature.
Led by a hand-picked team of biologists, technologists, and entrepreneurs with rebel hearts, Insempra is here to create a new school of thought and collective action. The time to restore the balance between people and the planet is now. We don’t wait for change. We do what needs to be done to grow a better future.
What is your motivation?
Brands and Original Equipment Manufacturers (OEMs) are generally poorly integrated into value chains. We believe in collaboration and drive innovation based on the properties of the chemicals required by customers and demanded by conscious citizens. This also means we have a flexible approach to technology development, investing in scouting for in-house but also licensing technologies. There has been no shortage of climate-focused innovation in labs and startups across the globe, but the science has been very difficult to scale.
Insempra is changing this by bridging the gap between R&D-focused organizations and brands/OEMs to bring products to market. Through our integrated medium and large-scale facilities, we create proper conditions for different volumes of production. Compared to traditional extractive economies, we can evaluate the socioecological impact along the lifecycle and value chain. We produce locally, avoiding global value chain disruption, independently of seasonality or geopolitical conflicts and guaranteeing predictability for sourcing.
“The IZB provides the perfect environment for us to hit the ground running and quickly scale our lab operations. We are excited to be surrounded by so many other interesting biotech players and believe it’s a highly attractive location to bring in additional talent from around the world to join us.”
Jens Klein, CEO